Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amrize (AMRZ) EBT (2024 - 2025)

Amrize (AMRZ) has disclosed EBT for 2 consecutive years, with $392.0 million as the latest value for Q4 2025.

  • Quarterly EBT rose 8.59% to $392.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Dec 2025, changed N/A year-over-year, with the annual reading at $1.5 billion for FY2025, 8.05% down from the prior year.
  • EBT hit $392.0 million in Q4 2025 for Amrize, down from $689.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $703.0 million in Q3 2024 to a low of $361.0 million in Q4 2024.